The Type B Leukemogenic Virus Truncated Superantigen Is Dispensable for T-Cell Lymphomagenesis

AUTOR(ES)

Mustafa, Farah

FONTE

American Society for Microbiology

RESUMO

Type B leukemogenic virus (TBLV) is a variant of mouse mammary tumor virus (MMTV) that causes T-cell lymphomas in mice. We have constructed a TBLV-MMTV hybrid, pHYB-TBLV, in which 756 bp of the C3H MMTV long terminal repeat (LTR) was replaced with 438 bp of the TBLV LTR. Intraperitoneal injection of pHYB-TBLV transfectants consistently resulted in T-cell lymphomas in 50% of injected weanling BALB/c mice with an average latency period of 5.7 (± 1.5) months. Transfectants of pHYB-TBLV containing a double-frameshift mutation in the truncated superantigen gene (sag) induced T-cell lymphomas with similar incidences, latency periods, and phenotypes, suggesting that cis-acting elements in the TBLV LTR determine disease specificity.

Documentos Relacionados

• Rorγ (Rorc) Is a Common Integration Site in Type B Leukemogenic Virus-Induced T-Cell Lymphomas
• T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.
• ROG Negatively Regulates T-Cell Activation but Is Dispensable for Th-Cell Differentiation
• Gadd45γ Is Dispensable for Normal Mouse Development and T-Cell Proliferation
• Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I